1. Home
  2. HYPD vs AMTD Comparison

HYPD vs AMTD Comparison

Compare HYPD & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYPD
  • AMTD
  • Stock Information
  • Founded
  • HYPD 2014
  • AMTD 2003
  • Country
  • HYPD United States
  • AMTD France
  • Employees
  • HYPD N/A
  • AMTD N/A
  • Industry
  • HYPD
  • AMTD
  • Sector
  • HYPD
  • AMTD
  • Exchange
  • HYPD NYSE
  • AMTD Nasdaq
  • Market Cap
  • HYPD 73.3M
  • AMTD 80.2M
  • IPO Year
  • HYPD 2018
  • AMTD 2019
  • Fundamental
  • Price
  • HYPD $12.52
  • AMTD $1.01
  • Analyst Decision
  • HYPD
  • AMTD
  • Analyst Count
  • HYPD 0
  • AMTD 0
  • Target Price
  • HYPD N/A
  • AMTD N/A
  • AVG Volume (30 Days)
  • HYPD 6.5M
  • AMTD 45.4K
  • Earning Date
  • HYPD 08-11-2025
  • AMTD 07-22-2025
  • Dividend Yield
  • HYPD N/A
  • AMTD N/A
  • EPS Growth
  • HYPD N/A
  • AMTD N/A
  • EPS
  • HYPD N/A
  • AMTD 0.76
  • Revenue
  • HYPD $67,063.00
  • AMTD $67,032,000.00
  • Revenue This Year
  • HYPD N/A
  • AMTD N/A
  • Revenue Next Year
  • HYPD N/A
  • AMTD N/A
  • P/E Ratio
  • HYPD N/A
  • AMTD $1.33
  • Revenue Growth
  • HYPD 663.82
  • AMTD N/A
  • 52 Week Low
  • HYPD $0.85
  • AMTD $0.92
  • 52 Week High
  • HYPD $124.80
  • AMTD $1.79
  • Technical
  • Relative Strength Index (RSI)
  • HYPD N/A
  • AMTD 50.39
  • Support Level
  • HYPD N/A
  • AMTD $0.98
  • Resistance Level
  • HYPD N/A
  • AMTD $1.06
  • Average True Range (ATR)
  • HYPD 0.00
  • AMTD 0.06
  • MACD
  • HYPD 0.00
  • AMTD -0.00
  • Stochastic Oscillator
  • HYPD 0.00
  • AMTD 46.31

About HYPD HYPERION DEFI INC

Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

Share on Social Networks: